Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Reata Pharmaceuticals presents new inhibitors of NO production

July 17, 2012

RNAi screen identifies targets for diseases involving protein misfolding

Jan. 13, 2012

Celtaxsys obtains anti-inflammatory drug from Estrellita Pharmaceuticals

Jan. 12, 2012

Novel anti-inflammatory agents discovered in U.K.

Jan. 11, 2012

Novel inhibitors of cytochrome P450 enzymes synthesized by Angion Biomedica

Jan. 5, 2012

Lilly withdraws Xigris worldwide following PROWESS-SHOCK study

Oct. 26, 2011

Karolinska Institutet presents novel series of selenium-containing antioxidants

May 6, 2011

Phase I trial to assess MLN-9708 in relapsed/refractory light chain amyloidosis under way

March 28, 2011

Roskamp Institute obtains IRB approval for study of RCP-006 in humans

March 4, 2011

AM-095 displays antifibrotic activity in vivo

Jan. 13, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...